Painreform is trading 5.31% up at $1.05 in after-hours trading, with no reliable company-specific announcement dated August 21 directly explaining the move.

  • It closed at $1.00 on August 21, 2026.
  • Available coverage mainly references earlier clinical updates and an annual-meeting item; the broader market finished higher, particularly the Nasdaq, but evidence is insufficient to attribute the move to macro sentiment.
  • The extended-hours gain remains unexplained and warrants monitoring for delayed filings or announcements.